EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 38 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $990,000 | +0.6% | 99,999 | 0.0% | 0.04% | +26.7% |
| Q1 2022 | $984,000 | +0.8% | 99,999 | 0.0% | 0.03% | +57.9% |
| Q4 2021 | $976,000 | -0.2% | 99,999 | 0.0% | 0.02% | +18.8% |
| Q3 2021 | $978,000 | -0.6% | 99,999 | 0.0% | 0.02% | +6.7% |
| Q2 2021 | $984,000 | -1.4% | 99,999 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $998,000 | -0.7% | 99,999 | 0.0% | 0.02% | +7.1% |
| Q4 2020 | $1,005,000 | – | 99,999 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 400,000 | $3,960,000 | 1.58% |
| 683 Capital Management, LLC | 600,000 | $5,941,000 | 0.42% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $1,980,000 | 0.34% |
| CVI Holdings, LLC | 367,552 | $3,639,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,999 | $9,900,000 | 0.20% |
| SkyView Investment Advisors, LLC | 71,773 | $710,000 | 0.19% |
| First Trust Capital Management L.P. | 169,858 | $1,682,000 | 0.12% |
| Cowen Investment Management LLC | 50,000 | $495,000 | 0.10% |
| Eisler Capital (UK) Ltd. | 310,294 | $3,072,000 | 0.10% |
| GLAZER CAPITAL, LLC | 325,806 | $3,222,000 | 0.08% |